Compare CRL & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | HMY |
|---|---|---|
| Founded | 1947 | 1950 |
| Country | United States | South Africa |
| Employees | N/A | 34350 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.8B |
| IPO Year | 1999 | N/A |
| Metric | CRL | HMY |
|---|---|---|
| Price | $214.20 | $15.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $198.27 | $16.00 |
| AVG Volume (30 Days) | 752.4K | ★ 3.8M |
| Earning Date | 05-07-2026 | 02-04-2016 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,857,601,000.00 | N/A |
| Revenue This Year | N/A | $37.43 |
| Revenue Next Year | $3.04 | $27.44 |
| P/E Ratio | ★ N/A | $15.60 |
| Revenue Growth | ★ 10.48 | N/A |
| 52 Week Low | $144.26 | $13.03 |
| 52 Week High | $228.88 | $26.04 |
| Indicator | CRL | HMY |
|---|---|---|
| Relative Strength Index (RSI) | 73.04 | 45.03 |
| Support Level | $193.41 | $14.95 |
| Resistance Level | $228.64 | $18.61 |
| Average True Range (ATR) | 7.45 | 0.62 |
| MACD | 2.68 | -0.13 |
| Stochastic Oscillator | 92.13 | 31.17 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.